Targeting mutant estrogen receptors.
Publication
, Journal Article
Wardell, SE; Norris, JD; McDonnell, DP
Published in: Elife
January 16, 2019
A drug used in hormone replacement therapy can target estrogen receptors that have become resistant to breast cancer treatments.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Elife
DOI
EISSN
2050-084X
Publication Date
January 16, 2019
Volume
8
Location
England
Related Subject Headings
- Selective Estrogen Receptor Modulators
- Receptors, Estrogen
- Mutation
- Mutant Proteins
- Humans
- Female
- Breast Neoplasms
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 31 Biological sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wardell, S. E., Norris, J. D., & McDonnell, D. P. (2019). Targeting mutant estrogen receptors. Elife, 8. https://doi.org/10.7554/eLife.44181
Wardell, Suzanne E., John D. Norris, and Donald P. McDonnell. “Targeting mutant estrogen receptors.” Elife 8 (January 16, 2019). https://doi.org/10.7554/eLife.44181.
Wardell SE, Norris JD, McDonnell DP. Targeting mutant estrogen receptors. Elife. 2019 Jan 16;8.
Wardell, Suzanne E., et al. “Targeting mutant estrogen receptors.” Elife, vol. 8, Jan. 2019. Pubmed, doi:10.7554/eLife.44181.
Wardell SE, Norris JD, McDonnell DP. Targeting mutant estrogen receptors. Elife. 2019 Jan 16;8.
Published In
Elife
DOI
EISSN
2050-084X
Publication Date
January 16, 2019
Volume
8
Location
England
Related Subject Headings
- Selective Estrogen Receptor Modulators
- Receptors, Estrogen
- Mutation
- Mutant Proteins
- Humans
- Female
- Breast Neoplasms
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 31 Biological sciences